Accessibility Menu
 
Minerva Neurosciences logo

Minerva Neurosciences

(NASDAQ) NERV

Current Price$6.09
Market Cap$261.38M
Since IPO (2014)-88%
5 Year-74%
1 Year+226%
1 Month-4%

Minerva Neurosciences Financials at a Glance

Market Cap

$261.38M

Revenue (TTM)

$0.00

Net Income (TTM)

$293.42M

EPS (TTM)

$-26.80

P/E Ratio

-0.23

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$6.09

Volume

26,089

Open

$6.46

Previous Close

$6.09

Daily Range

$5.74 - $6.46

52-Week Range

$1.15 - $12.46

NERV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Minerva Neurosciences

Industry

Biotechnology

Employees

7

CEO

Rémy Henri Luthringer, PhD

Headquarters

Burlington, MA 02451, US

NERV Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-16%

Return on Assets

-3%

Earnings Yield

-4.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$261.38M

Shares Outstanding

43.27M

Volume

26.09K

Short Interest

0.00%

Avg. Volume

204.76K

Financials (TTM)

Gross Profit

$5.44K

Operating Income

$15.10M

EBITDA

$15.10M

Operating Cash Flow

$13.51B

Capital Expenditure

$0.00

Free Cash Flow

$13.51B

Cash & ST Invst.

$82.30M

Total Debt

$64.96M

Minerva Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.36K

N/A

Gross Margin

0.00%

N/A

Market Cap

$261.38M

N/A

Market Cap/Employee

$32.67M

N/A

Employees

8

N/A

Net Income

$283.67M

-6540.1%

EBITDA

$4.98M

-16.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$17.34M

-18.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-3.00%

N/A

Return on Invested Capital

-15.79%

N/A

Free Cash Flow

$4.48M

-3.0%

Operating Cash Flow

$4.48M

-3.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NRXSNeurAxis, Inc.
$7.05-3.56%
RLYBRallybio Corporation
$8.67-4.83%
XCURExicure, Inc.
$4.47+1.82%
ENLVEnlivex Therapeutics Ltd.
$1.10-0.90%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.55-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.00+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$78.50+0.02%
IBITiShares Bitcoin Trust
$39.28-0.02%

Questions About NERV

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.